Indolylmaleimide derivatives as protein kinase C inhibitors

Details for Australian Patent Application No. 2002221810 (hide)

Owner Novartis AG

Inventors Zenke, Gerhard; Wagner, Jurgen; Von Matt, Peter; Sedrani, Richard; Evenou, Jean-Pierre; Ehrhardt, Claus; Cottens, Sylvain; Cooke, Nigel Graham; Albert, Rainer

Agent Davies Collison Cave

Pub. Number AU-B-2002221810

PCT Pub. Number WO02/38561

Priority 60246400 07.11.00 US; 60283705 13.04.01 US

Filing date 5 November 2001

Wipo publication date 21 May 2002

Acceptance publication date 23 June 2005

International Classifications

C07D 403/04 Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

A61P 037/06 Drugs for immunological or allergic disorders

A61P 029/00 Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61K 031/404

C07D 403/14 Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

Event Publications

23 June 2005 Application Accepted

  Published as AU-B-2002221810

20 October 2005 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002221811

2002221809-Coatings consisting of special polyols and oxalic acid